Modular Medical to Present at the Lytham Partners Spring 2024 Investor Conference on May 30
Modular Medical (NASDAQ: MODD), a development-stage company focused on innovative insulin delivery technologies, announced its participation in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024. The conference will be held virtually, and the company will deliver a webcasted presentation at 3:30 p.m. ET. CEO Jeb Besser will also host one-on-one meetings with investors. The webcast can be accessed through the conference home page and will be available for replay.
- Participation in a prominent investor conference, indicating heightened visibility and potential investor interest.
- Virtual format allows for broader reach and accessibility.
- CEO Jeb Besser's involvement in one-on-one meetings suggests proactive investor engagement.
- No specific new product or financial updates provided in the announcement.
- The reliance on virtual participation may limit personal connection with potential investors.
SAN DIEGO, CA / ACCESSWIRE / May 21, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2024 Investor Conference, taking place virtually on Thursday, May 30, 2024.
Company Webcast
The Company's webcasted presentation will take place at 3:30 p.m. ET on Thursday, May 30, 2024. The webcast can be accessed by visiting the conference home page at http://lythampartners.com/spring2024/ and will also be available for replay following the event.
1×1 Meetings
Jeb Besser, the Company's Chief Executive Officer, will host virtual one-on-one meetings throughout the event. To arrange a meeting with Mr. Besser, please contact Lytham Partners at 1×1@lythampartners.com or register for the event at https://lythampartners.com/spring2024invreg/ .
About Modular Medical
Modular Medical, Inc. (Nasdaq: MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Our mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."
Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.
All trademarks mentioned herein are the property of their respective owners.
CONTACT:
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com
SOURCE: Modular Medical, Inc.
View the original press release on accesswire.com
FAQ
What is the date of Modular Medical's presentation at the Lytham Partners Spring 2024 Investor Conference?
At what time is Modular Medical's webcasted presentation scheduled during the conference?
How can investors access the webcast of Modular Medical's presentation?
Will the webcast of Modular Medical's presentation be available after the event?
Who will be hosting one-on-one meetings from Modular Medical at the conference?
